Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 200624

Expand all

REPAGLINIDE AND METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE; REPAGLINIDE)
500MG;1MG
Marketing Status: Discontinued

Active Ingredient: METFORMIN HYDROCHLORIDE; REPAGLINIDE
Proprietary Name: REPAGLINIDE AND METFORMIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG;1MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A200624
Product Number: 001
Approval Date: Jul 15, 2015
Applicant Holder Full Name: LUPIN LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information

REPAGLINIDE AND METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE; REPAGLINIDE)
500MG;2MG
Marketing Status: Discontinued

Active Ingredient: METFORMIN HYDROCHLORIDE; REPAGLINIDE
Proprietary Name: REPAGLINIDE AND METFORMIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG;2MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A200624
Product Number: 002
Approval Date: Jul 15, 2015
Applicant Holder Full Name: LUPIN LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information